The Adtec Phakic IOL Family represents a new standard in refractive correction for high myopia.
Designed for implantation without altering the eye’s natural crystalline structure, these lenses offer high refractive accuracy, superior optical quality, and rapid visual recovery — enabling surgeons to achieve stable outcomes with minimal invasiveness.
The Adtec Multi features a double aspheric optic engineered for exceptional visual performance at both near and distance.
These lenses incorporate a natural yellow chromophore that offers balanced photoprotection across the UV and violet spectrum without compromising colour perception— delivering patient satisfaction with minimal dysphotopsia.
The Adtec Mono EDOF IOL provides an extended depth of focus with remarkable image quality and contrast sensitivity.
Designed for surgeons who value precision and flexibility, it reduces spectacle dependence for intermediate tasks — making it ideal for active patients seeking Intermediate vision without compromising distance clarity.
The Adtec Trifocal EDOF unites the strengths of trifocal and EDOF optics to deliver smooth, continuous vision from 32 cm to infinity
Engineered for visual independence, it provides crisp intermediate and distance performance with excellent neuroadaptation — making it a surgeon’s preferred choice for premium cataract patients.
The Adtec Trifocal IOL delivers seamless vision across near, intermediate, and far distances with natural visual transitions.
Its optical design minimises halos and glare while enhancing contrast, making it ideal for cataract patients who desire complete spectacle independence and comfort in all lighting conditions.
The Adtec Monofocal IOL offers superior clarity, contrast, and centration for distance vision.
Built for reliability and ease of implantation, this IOL remains the gold standard for surgeons seeking simplicity, precision, and long-term stability for their patients.
The Adtec Advanced Monofocal IOL bridges the gap between standard Monofocal and EDOF technology.
Its enhanced aspheric profile improves intermediate vision while maintaining excellent distance focus — offering surgeons a versatile solution for patients desiring extended functionality with Monofocal comfort.
The Adtec Toric Family is crafted with nanoform precision technology to ensure exact spherical and cylindrical power alignment.
Our patented Adtec Lock Haptic Design provides auto-centration, high capsular stability, and minimal postoperative rotation, ensuring consistent refractive accuracy and predictable outcomes — even in complex astigmatic cases.
Cataracts remain the leading cause of treatable blindness globally. With over half of all blindness linked to cataracts, surgical excellence and IOL quality are critical for restoring functional vision.
At Adaptive Ocular Sciences, we partner with surgeons to advance cataract outcomes through:
Surgery is more than treatment — it’s restoration.
Adtec IOLs empower surgeons to deliver lasting clarity, confident results, and renewed quality of life for every patient.
As a radiologist, the transformation in my vision since receiving the Xtend EDOF Trifocal lenses has been remarkable. I'm absolutely thrilled with the outcome! No longer dependent on spectacles, I can now examine X-ray plates with enhanced clarity and contrast, making my job much more efficient.
With Comfort Toric in both eyes, I have clear, sharp distance vision and no issues with night driving. I don't experience any visual disturbances like the glare from car headlights.
I've had Comfort implanted in both eyes. Now, I can do various activities without glasses, like watching TV, using my mobile, and even making ATM withdrawals. However, for reading fine print, I still need 1.5D power glasses, just like when I was 40 years old.
Adaptive Ocular Sciences Pvt. Ltd. is one of the fastest-growing innovators in intraocular lens manufacturing. We provide a comprehensive range of advanced IOLs for refractive cataract surgery, integrating innovative optical design and engineering to deliver exceptional visual quality and patient outcomes.
